Precision Medicine Innovation Not Just a Numbers Game

We published a revision to our Precision Medicine Scorecard: Drug Company Edition last month. As John Audette rightfully notes, there are multiple factors in a pharmaceutical company’s contribution to precision medicines: How many precision medicines a company...

Chart of the Week: Celgene Precision Medicine Activities Graph

We’ve been curious about Celgene’s activity in precision medicine for some time.  We’ve posted blog posts here, here and here proposing that Celgene’s activities are indicative of a precision medicine push.  As a supplement, this weeks CotW is...

What’s new in Biomarker Base ? … Biomarker Workspace View

Personalized medicine is an exciting space that is moving and changing quickly.  Staying on top of the changes and identifying parallel opportunities is difficult.  How do you identify what disease areas are complementary to your existing product strategy?  What is...